Catalyst Wire Dossier Catalyst Wire Dossier

Oculeve Intranasal Neurostimulator

· Oculeve, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Oculeve Intranasal Neurostimulator, covering 2017-10-25 to 2017-10-25. Get the full timeline:

Most recent: Clinical Trial Update: Acute Tear Production Following Single Use of the Oculeve Intranasal Neurostimulator [NA]

See pricing